Stockreport

Evaxion announces business update and full year 2024 financial results

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered v [Read more]